Interestingly, the decreased expression of ESR2, APP, and SPG7, direct interactors of ALDOA and ENO1 of the glycolytic pathway, has been confirmed in the cervical and lumbar regions of an independent cohort of ALS patients. Here, ALDOA is linked to amyotrophic lateral sclerosis.